FDA Person
FDAScott T. Ballard
View detailed information about Scott T. Ballard, including compliance records, violations, and related data.
Person Profile
FDA investigator. Took part in 60 inspections of 58 companies, 2016–2026.
Inspections (60)
| Date | Company | Classification | Project area | Inspection |
|---|---|---|---|---|
| September 29, 2026 | Pharmacia & Upjohn Company LLC | Not classified | Blood and Blood Products | #1295014 |
| August 20, 2026 | Baxter Healthcare Corporation | Not classified | Monitoring of Marketed Animal Drugs, Feed, and Devices | #1299166 |
| June 23, 2026 | Bristol-Myers Squibb Company | Not classified | #1327472 | |
| March 24, 2026 | StemCyte, Inc | Not classified | Human Cellular, Tissue, and Gene Therapies | #1291150 |
| February 5, 2026 | Fenwal International, Inc. | Not classified | Blood and Blood Products | #1294942 |
| December 18, 2025 | MassBiologics | VAI | Human Cellular, Tissue, and Gene Therapies | #1295884 |
| November 4, 2025 | Juno Therapeutics, Inc. | Not classified | #1287586 | |
| July 29, 2025 | Seres Therapeutics Inc | NAI | Vaccines and Allergenic Products | #1279457 |
| July 25, 2025 | Seres Therapeutics, Inc. | NAI | Vaccines and Allergenic Products | #1276673 |
| June 26, 2025 | Ferring Microbiome Inc. | VAI | Vaccine, Allergenic, and Live Biotherapeutic Products | #1275160 |
| May 9, 2025 | Barr Laboratories Inc. | VAI | Vaccine, Allergenic, and Live Biotherapeutic Products | #1253861 |
| April 18, 2025 | AGC Biologics, Inc. | Not classified | #1265749 | |
| March 20, 2025 | 2seventy Bio, Inc. | Not classified | #1265757 | |
| February 7, 2025 | Charles River Laboratories Inc | Not classified | Human Cellular, Tissue, and Gene Therapies | #1260289 |
| November 22, 2024 | Henogen SRL | Not classified | #1254773 | |
| November 12, 2024 | Boehringer Ingelheim RCV GmbH & Co KG | NAI | Vaccines and Allergenic Products | #1258048 |
| September 18, 2024 | Fenwal International, Inc. | VAI | Blood and Blood Products | #1250072 |
| August 2, 2024 | Sanofi Vaccines US Inc. | VAI | Vaccines and Allergenic Products | #1229985 |
| June 17, 2024 | Oxford Biomedica (UK) Limited | NAI | Human Cellular, Tissue, and Gene Therapies | #1245371 |
| June 17, 2024 | Oxford Biomedica (UK) Limited | NAI | Human Cellular, Tissue, and Gene Therapies | #1245331 |
Documents (65)
- 483 · Downing Labs, LLC · November 19, 2018
- 483 · QuVa Pharma, Inc. · April 2, 2014
- 483 · Pharmedium Services, LLC · February 27, 2013
- 483 · Cantrell Drug Company · March 22, 2018
- 483 · QuVa Pharma, Inc. · April 20, 2018
- 483 · QuVa Pharma, Inc. · June 20, 2014
- 483 · US Compounding Inc · July 15, 2016
- 483 · Abrams Royal Pharmacy · December 20, 2013
- 483 · IV Solutions of Lubbock · March 20, 2013
- 483 · I.V. Specialty, Ltd · July 28, 2017
- 483 · Sun Pharmaceutical Industries Ltd. · February 23, 2018
- EIR · FUJIFILM Diosynth Biotechnologies Texas, LLC · August 31, 2021
- 483 · Central Admixture Pharmacy Services, Inc. · August 8, 2014
- 483 · Eugia Pharma Specialities Limited · April 28, 2017
- EIR · Merck Sharp & Dohme LLC · April 16, 2021
- EIR · Abbott Laboratories · September 24, 2021
- 483 · Eugia Pharma Specialities Limited · September 16, 2016
- EIR · Brammer Bio MA, LLC · February 10, 2021
- EIR · Lonza Houston, Inc · December 10, 2020
- 483 · Ferring Microbiome Inc. · June 26, 2025
- 483 · Kite Pharma, Inc. · August 20, 2019
- 483 · Patheon Italia S.p.A. · September 29, 2023
- 483 · Octapharma AB · September 19, 2023
- 483 · Merck Sharp & Dohme LLC · April 16, 2021
- 483 · Novartis Gene Therapies, Inc. · August 2, 2019
- 483 · Charles River Laboratories Inc · February 7, 2025
- 483 · MassBiologics · December 18, 2025
- EIR · Patheon Italia S.p.A. · September 29, 2023
- 483 · AGC Biologics, Inc. · April 18, 2025
- 483 · Adimmune Corporation
- 483 · Right Cell, LLC · August 3, 2021
- 483 · Takeda Pharmaceutical Company Limited · September 18, 2015
- 483 · Fenwal International, Inc. · September 18, 2024
- 483 · Shiva Analyticals (India) Pvt. Ltd. · February 24, 2016
- 483 · CellSure, L3C · August 2, 2021
- EIR · Sovereign Pharmaceuticals, LLC · November 10, 2016
- EIR · Lonza Tampa LLC · July 20, 2018
- EIR · Sovereign Pharmaceuticals, LLC · January 8, 2016
- 483 · Orca Biotech LLC · August 5, 2021
- 483 · University of Utah Cell Therapy and Regenerative Medicine · July 13, 2018
- 483 · Fenwal International, Inc. · April 25, 2023
- EIR · Kite Pharma, Inc. · August 20, 2019
- 483 · MiMedx Group, Inc. · December 12, 2019
- 483 · Sanofi Vaccines US Inc. · August 2, 2024
- EIR · Grander Acquisition LLC · July 13, 2018
- 483 · Henogen SRL · November 22, 2024
- 483 · Brammer Bio MA, LLC · February 10, 2021
- 483 · Brammer Bio MA, LLC · February 10, 2021
- 483 · Sarepta Therapeutics Inc · March 24, 2023
- 483 · Grander Acquisition LLC · July 13, 2018
- 483 · Lonza Houston, Inc · December 10, 2020
- EIR · Vetter Pharma Fertigung GmbH & Co. KG · December 12, 2014
- 483 · VetGraft, LLC · November 14, 2022
- 483 · Barr Laboratories Inc. · May 9, 2025
- 483 · Baxter Healthcare Corporation · October 31, 2023
- 483 · Baxter Pharmaceutical Solutions, LLC · November 10, 2021
- 483 · Fenwal International, Inc. · September 24, 2022
- 483 · Zach System S.A. · October 25, 2018
- 483 · FUJIFILM Diosynth Biotechnologies Texas, LLC · August 31, 2021
- 483 · bluebird bio, Inc. · March 20, 2025
- 483 · Kedrion S.p.A. · June 24, 2022
- EIR · 3RODULW 7( ,QF · July 13, 2018
- 483 · Fenwal International, Inc. · February 5, 2026
- 483 · Ultragenyx Pharmaceutical Inc.
- 483 · Kedrion Biopharma Inc. · May 21, 2026
Frequently inspected with (10)
Alan L. Truong
4 shared
Brian R. Yaun
investigator
3 shared
Gene D. Arcy
3 shared
Alexandra B. Pitkin
Investigator
2 shared
Christian D. Lynch
investigator
2 shared
Cody D. Rickman
2 shared
Kelly D. Moore
Manager, Data Science and Engineering
2 shared
Lillian C. Hsu
2 shared
Matthew L. Doyle
2 shared
Matthew R. Noonan
Burns & McDonnell
2 shared
Person Information
Name
Scott T. Ballard
Role
Regulatory Personnel
ID: 09b2ae9a-3b30-45bd-bac1-437365e938da
Get More Insights
Access our comprehensive quality intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
1.5M+ regulatory data points
Real-time compliance monitoring
Interactive analytics dashboard
Looking for more people? Our platform provides access to thousands of FDA people with advanced search and filtering capabilities.
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.